The Ryan Institute for Neuroscience is dedicated to the prevention and treatment of neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), aging-related illness, and other central nervous system disorders.
Recent News
- $413,729 NIH grant helps to study the link between stroke and Alzheimer’s disease January 4, 2024 - Assistant Professor Claudia Fallini hopes the research will lead to new Alzheimer's disease insights and improved stroke outcomes.
- Van Nostrand lab collaborates with Eli Lilly to investigate brain bleed risk in Alzheimer’s disease treatments January 2, 2024 - The project will help shed light on whether there may be a way to reduce or eliminate the risk.
- $8.5 million in NIH grants support Ryan Institute research to help treat cerebral palsy September 9, 2023 - Assistant Professor Katharina Quinlan is principal investigator on two new grants that could repurpose existing therapeutics to treat the disorder.
- A new study investigates the impact of microplastics in the brain August 4, 2023 - Assistant Professor Jaime Ross and her lab report surprising findings on the impact of short-term microplastics exposure through drinking water.
We’re hiring
Are you a mid-career researcher in the field of Alzheimer’s disease and related disorders?
“Solving neurodegenerative disease is going to be a global effort. But if we work together, we can have a much better result.”Tom Ryan ‘75, Hon. ‘99